Literature DB >> 18379991

Protein self-modification by heme-generated reactive species.

Enrico Monzani1, Stefania Nicolis, Raffaella Roncone, Marica Barbieri, Alessandro Granata, Luigi Casella.   

Abstract

In the presence of H(2)O(2), heme proteins form active intermediates, which are able to oxidize exogenous molecules. Often these products are not stable compounds but reactive species on their own, such as organic radicals. They can both diffuse to the bulk of the solution or react with the protein that generated them. Here, we describe the self-modification underwent by heme proteins with globin-type fold, that is, myoglobin, hemoglobin, and neuroglobin when treated with NO(2) (-) or catechols in the presence of H(2)O(2). The reactive nitrogen species generated by NO(2) (-) give rise to nitration, oxidation, and/or crosslinking reactions between the proteins or their subunits. The quinones formed upon reaction with catechols easily modify Cys and His residues and eventually cause protein aggregation, which induces precipitation. The pattern of modifications undergone by the protein strongly depends on the nature of the protein and the reaction conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379991     DOI: 10.1002/iub.10

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  2 in total

1.  Peroxynitrite chemistry derived from nitric oxide reaction with a Cu(II)-OOH species and a copper mediated NO reductive coupling reaction.

Authors:  Sunghee Kim; Maxime A Siegler; Kenneth D Karlin
Journal:  Chem Commun (Camb)       Date:  2013-12-09       Impact factor: 6.222

2.  Pseudoperoxidase activity, conformational stability, and aggregation propensity of the His98Tyr myoglobin variant: implications for the onset of myoglobinopathy.

Authors:  Stefan Hofbauer; Marcello Pignataro; Marco Borsari; Carlo Augusto Bortolotti; Giulia Di Rocco; Gianina Ravenscroft; Paul G Furtmüller; Christian Obinger; Marco Sola; Gianantonio Battistuzzi
Journal:  FEBS J       Date:  2021-11-03       Impact factor: 5.622

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.